At a glance
More than 130 years of research and innovation experience
Owned by the founding family since 1885
One of the pharmaceutical industry’s top 20 companies
Global market position in animal health and biopharmaceuticals
Global Leader in biopharmaceuticals since 1986
Winner of 2018 International Prix Galien – Best Pharmaceutical Product for Jardiance® diabetes treatment
Providing animal health products in 150 markets worldwide
Net sales of around 17.5 billion euros in 2018
R&D expenses of €3.2 billion euros – corresponding to 18.1% of net sales
Our priority is discovering, developing and delivering products and treatments that will improve the health of humans and animals around the world. Research into new and innovative medicines is focused on unmet needs in disease areas where we have built significant expertise over time.
Human pharmaceuticals, our largest business, accounted for 72% of our total net sales in 2018. As a leading pharmaceutical company, trusted by healthcare professionals and patients, we’re committed to providing prescription medicines and healthcare solutions which address many of the world’s greatest health challenges.
We would like to welcome you warmly to Boehringer Ingelheim and thank you for joining our team. We are really looking forward to working with you and we wish you success in your new role!